Fred Hutchinson Cancer Center's Role in Advancing Blood and Marrow Transplants
BMT CTN Core - Fred Hutchinson Cancer Center
This grant helps the Fred Hutchinson Cancer Center lead and participate in many clinical trials for patients needing blood and marrow transplants or cellular therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Fred Hutchinson Cancer Center NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11164695 on NIH RePORTER |
What this research studies
The Fred Hutchinson Cancer Center is a key part of a national network dedicated to improving blood and marrow transplantation (BMT) and cellular therapies for patients with blood diseases and cancer. For over two decades, this center has been instrumental in conducting numerous clinical trials, helping to find better ways to perform transplants, prevent complications like graft-versus-host disease, and reduce the risk of cancer returning. Their extensive experience and high patient enrollment mean that many individuals have the opportunity to participate in cutting-edge research aimed at improving their outcomes. This work helps advance the field, leading to safer and more effective treatments for patients.
Who could benefit from this research
Good fit: Patients with blood diseases or cancers who are considering or undergoing blood and marrow transplantation or cellular therapies may benefit from the research supported by this center.
Not a fit: Patients who do not have blood diseases or cancers requiring blood and marrow transplantation or cellular therapies would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this ongoing work will continue to improve the safety and effectiveness of blood and marrow transplants and cellular therapies, leading to better health and longer lives for patients with serious blood diseases and cancers.
How similar studies have performed: The Bone Marrow Transplant Clinical Trials Network (BMT CTN) has a long history of successfully conducting clinical trials that have significantly advanced the field of hematopoietic cell transplantation.
Where this research is happening
Seattle, United States
- Fred Hutchinson Cancer Center — Seattle, United States (Active)
Researchers
- Principal investigator: Lee, Stephanie J — Fred Hutchinson Cancer Center
- Study coordinator: Lee, Stephanie J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.